Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours

Xiaotu Ma(St. Jude Children's Research Hospital), Yu Liu(St. Jude Children's Research Hospital), Yanling Liu(St. Jude Children's Research Hospital), Ludmil B. Alexandrov(University of California San Diego), Michael N. Edmonson(St. Jude Children's Research Hospital), Charles Gawad(St. Jude Children's Research Hospital), Xin Zhou(St. Jude Children's Research Hospital), Yongjin Li(St. Jude Children's Research Hospital), Michael Rusch(St. Jude Children's Research Hospital), John Easton(St. Jude Children's Research Hospital), Robert Huether(Oldham Council), Veronica Gonzalez-Pena(St. Jude Children's Research Hospital), Mark R. Wilkinson(St. Jude Children's Research Hospital), Leandro C. Hermida(National Cancer Institute), Sean Davis(National Cancer Institute), Edgar Sioson(St. Jude Children's Research Hospital), Stanley Pounds(St. Jude Children's Research Hospital), Xueyuan Cao(St. Jude Children's Research Hospital), Rhonda E. Ries(Fred Hutch Cancer Center), Zhaoming Wang(St. Jude Children's Research Hospital), Xiang Chen(St. Jude Children's Research Hospital), Li Dong(St. Jude Children's Research Hospital), Sharon J. Diskin(Children's Hospital of Philadelphia), Malcolm A. Smith(National Cancer Institute), Jaime M. Guidry Auvil(National Cancer Institute), Paul S. Meltzer(National Cancer Institute), Ching C. Lau(Connecticut Children's Medical Center), Elizabeth J. Perlman(Northwestern University), John M. Maris(Children's Hospital of Philadelphia), Soheil Meshinchi(Fred Hutch Cancer Center), Stephen P. Hunger(Children's Hospital of Philadelphia), Daniela S. Gerhard(National Cancer Institute), Jinghui Zhang(St. Jude Children's Research Hospital)
Nature
February 28, 2018
Cited by 939Open Access
Full Text

Abstract

Analysis of molecular aberrations across multiple cancer types, known as pan-cancer analysis, identifies commonalities and differences in key biological processes that are dysregulated in cancer cells from diverse lineages. Pan-cancer analyses have been performed for adult but not paediatric cancers, which commonly occur in developing mesodermic rather than adult epithelial tissues. Here we present a pan-cancer study of somatic alterations, including single nucleotide variants, small insertions or deletions, structural variations, copy number alterations, gene fusions and internal tandem duplications in 1,699 paediatric leukaemias and solid tumours across six histotypes, with whole-genome, whole-exome and transcriptome sequencing data processed under a uniform analytical framework. We report 142 driver genes in paediatric cancers, of which only 45% match those found in adult pan-cancer studies; copy number alterations and structural variants constituted the majority (62%) of events. Eleven genome-wide mutational signatures were identified, including one attributed to ultraviolet-light exposure in eight aneuploid leukaemias. Transcription of the mutant allele was detectable for 34% of protein-coding mutations, and 20% exhibited allele-specific expression. These data provide a comprehensive genomic architecture for paediatric cancers and emphasize the need for paediatric cancer-specific development of precision therapies.


Related Papers

No related papers found

Powered by citation graph analysis